Antithetical Impacts of Deleterious LRP1B Mutations in Non-Squamous and Squamous NSCLCs on Predicting Benefits from Immune Checkpoint Inhibitor Alone or with Chemotherapy over Chemotherapy Alone: Retrospective Analyses of the POPLAR/OAK and CHOICE-01 Trials
Science China Life Sciences（2024）
Key words
non-squamous NSCLC,squamous NSCLC,LRP1B deleterious mutations,predictive biomarker,immune checkpoint inhibitor
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined